Table 2.
Contingency of the respiratory support, Azithromycin (AZT) and comorbidity and needs at baseline.
| Group | |||||
|---|---|---|---|---|---|
| Control | Treatment | Tot | |||
| Airways support | No (%) | 27.30 | 31.75 | 59.05 | |
| Yes (%) | 18.20 | 22.75 | 40.95 | χ2 = 0.006 | |
| Tot (%) | 45.50 | 54.50 | 100.00 | p = 0.640 | |
| AZT | No (%) | 22.75 | 31.75 | 54.50 | |
| Yes (%) | 22.75 | 22.75 | 45.50 | χ2 = 0.067 | |
| Tot (%) | 45.50 | 54.50 | 100.00 | p = 0.560 | |
| Hypertension | No (%) | 22.75 | 40.90 | 63.60 | |
| Yes (%) | 22.75 | 13.60 | 36.35 | χ2 = 1.470 | |
| Tot (%) | 45.50 | 54.50 | 100.00 | p = 0.221 | |
| Diabetes mellitus | No (%) | 31.80 | 50.00 | 81.80 | |
| Yes (%) | 13.70 | 4.50 | 18.10 | χ2 = 1.720 | |
| Tot (%) | 45.50 | 54.50 | 100.00 | p = 0.225 | |
| Dementia | No (%) | 41.00 | 50.00 | 91.00 | |
| Yes (%) | 4.50 | 4.50 | 9.00 | χ2 = 0.180 | |
| Tot (%) | 45.50 | 54.50 | 100.00 | p = 0.745 | |
The data are shown as percentages. Among groups, the presence of difference in aspect ratio was analyzed with the Chi square test, statistical significance was attributed as p <0.05.